Caribou Biosciences (CRBU) shares fell over 22% in Thursday trading after HC Wainwright downgraded the stock to neutral from buy.

Trading volume stood at nearly 18 million shares, compared with a daily average of about 1.9 million.

Price: 0.48, Change: -0.14, Percent Change: -22.24